HCW Biologics (HCWB) Payables (2020 - 2025)
HCW Biologics' (HCWB) quarterly Payables came in at $6.9 million in Q4 2025, down 75.82% YoY from $28.6 million in Q4 2024, and down 73.12% on a QoQ basis from $25.8 million in Q3 2025.
HCW Biologics (HCWB) Payables (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Payables data on file, last reported at $6.9 million in Q4 2025.
- Quarterly Payables fell 75.82% year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (down 75.82% YoY) and the FY2025 annual result came in at $6.9 million, down 75.82% from the prior year.
- Payables retreated to $6.9 million in Q4 2025, from $25.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $29.0 million in Q3 2024 to a low of $223664.0 in Q4 2021.
- A 5-year average of $8.3 million and a median of $2.6 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables soared 1161.16% — and 2025, when it sank 75.82%.
- Tracing HCWB's Payables over 5 years: stood at $223664.0 in 2021, then surged by 660.07% to $1.7 million in 2022, then soared by 52.94% to $2.6 million in 2023, then jumped by 1001.81% to $28.6 million in 2024, then slumped by 75.82% to $6.9 million in 2025.
- The last three Payables figures came in at $6.9 million (Q4 2025), $25.8 million (Q3 2025), and $25.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 17.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.93 Mn |
| Sep 30, 2025 | 25.78 Mn |
| Jun 30, 2025 | 25.78 Mn |
| Mar 31, 2025 | 7.43 Mn |
| Dec 31, 2024 | 28.65 Mn |
| Sep 30, 2024 | 29.01 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 10.49 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.30 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 882,775.00 |
| Jun 30, 2022 | 848,340.00 |
| Mar 31, 2022 | 674,000.00 |
| Dec 31, 2021 | 223,664.00 |
| Sep 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | 996,880.00 |
| Dec 31, 2020 | 155,343.00 |